Abstract
Anorexia nervosa and bulimia nervosa are prevalent illnesses affecting between 1% and 10% of adolescent and college age women. Developmental, family dynamic, and biologic factors are all important in the cause of this disorder. Anorexia nervosa is diagnosed when a person refuses to maintain his or her body weight over a minimal normal weight for age and height, such as 15% below that expected, has an intense fear of gaining weight, has a disturbed body image, and, in women, has primary or secondary amenorrhea. A diagnosis of bulimia nervosa is made when a person has recurrent episodes of binge eating, a feeling of lack of control over behavior during binges, regular use of self-induced vomiting, laxatives, diuretics, strict dieting, or vigorous exercise to prevent weight gain, a minimum of 2 binge episodes a week for at least 3 months, and persistent overconcern with body shape and weight. Patients with eating disorders are usually secretive and often come to the attention of physicians only at the insistence of others. Practitioners also should be alert for medical complications including hypothermia, edema, hypotension, bradycardia, infertility, and osteoporosis in patients with anorexia nervosa and fluid or electrolyte imbalance, hyperamylasemia, gastritis, esophagitis, gastric dilation, edema, dental erosion, swollen parotid glands, and gingivitis in patients with bulimia nervosa. Treatment involves combining individual, behavioral, group, and family therapy with, possibly, psychopharmaceuticals. Primary care professionals are frequently the first to evaluate these patients, and their encouragement and support may help patients accept treatment. The treatment proceeds most smoothly if the primary care physician and psychiatrist work collaboratively with clear and frequent communication.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersen A. E., Mickalide A. D. Anorexia nervosa in the male: an underdiagnosed disorder. Psychosomatics. 1983 Dec;24(12):1066–1075. doi: 10.1016/S0033-3182(83)73105-1. [DOI] [PubMed] [Google Scholar]
- Bond W. S., Crabbe S., Sanders M. C. Pharmacotherapy of eating disorders: a critical review. Drug Intell Clin Pharm. 1986 Sep;20(9):659–665. doi: 10.1177/106002808602000903. [DOI] [PubMed] [Google Scholar]
- Brotman A. W., Rigotti N., Herzog D. B. Medical complications of eating disorders: outpatient evaluation and management. Compr Psychiatry. 1985 May-Jun;26(3):258–272. doi: 10.1016/0010-440x(85)90071-9. [DOI] [PubMed] [Google Scholar]
- Bruch H. Anorexia Nervosa: therapy and theory. Am J Psychiatry. 1982 Dec;139(12):1531–1538. doi: 10.1176/ajp.139.12.1531. [DOI] [PubMed] [Google Scholar]
- Carlat D. J., Camargo C. A., Jr Review of bulimia nervosa in males. Am J Psychiatry. 1991 Jul;148(7):831–843. doi: 10.1176/ajp.148.7.831. [DOI] [PubMed] [Google Scholar]
- Drewnowski A., Yee D. K., Krahn D. D. Bulimia in college women: incidence and recovery rates. Am J Psychiatry. 1988 Jun;145(6):753–755. doi: 10.1176/ajp.145.6.753. [DOI] [PubMed] [Google Scholar]
- Eckert E. D., Mitchell J. E. An overview of the treatment of anorexia nervosa. Psychiatr Med. 1989;7(4):293–315. [PubMed] [Google Scholar]
- Edelstein C. K., Yager J., Gitlin M., Landsverk J. A clinical study of anti-depressant medications in the treatment of bulimia. Psychiatr Med. 1989;7(3):111–121. [PubMed] [Google Scholar]
- Fairburn C. G., Kirk J., O'Connor M., Anastasiades P., Cooper P. J. Prognostic factors in bulimia nervosa. Br J Clin Psychol. 1987 Sep;26(Pt 3):223–224. doi: 10.1111/j.2044-8260.1987.tb01349.x. [DOI] [PubMed] [Google Scholar]
- Fairburn C. A cognitive behavioural approach to the treatment of bulimia. Psychol Med. 1981 Nov;11(4):707–711. doi: 10.1017/s0033291700041209. [DOI] [PubMed] [Google Scholar]
- Fava M., Copeland P. M., Schweiger U., Herzog D. B. Neurochemical abnormalities of anorexia nervosa and bulimia nervosa. Am J Psychiatry. 1989 Aug;146(8):963–971. doi: 10.1176/ajp.146.8.963. [DOI] [PubMed] [Google Scholar]
- Garfinkel P. E., Garner D. M., Rose J., Darby P. L., Brandes J. S., O'Hanlon J., Walsh N. A comparison of characteristics in the families of patients with anorexia nervosa and normal controls. Psychol Med. 1983 Nov;13(4):821–828. doi: 10.1017/s0033291700051539. [DOI] [PubMed] [Google Scholar]
- Garfinkel P. E., Kline S. A., Stancer H. C. Treatment of anorexia nervosa using operant conditioning techniques. J Nerv Ment Dis. 1973 Dec;157(6):428–433. doi: 10.1097/00005053-197312000-00004. [DOI] [PubMed] [Google Scholar]
- Garner D. M., Olmsted M. P., Polivy J., Garfinkel P. E. Comparison between weight-preoccupied women and anorexia nervosa. Psychosom Med. 1984 May-Jun;46(3):255–266. doi: 10.1097/00006842-198405000-00007. [DOI] [PubMed] [Google Scholar]
- Geracioti T. D., Jr, Liddle R. A. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med. 1988 Sep 15;319(11):683–688. doi: 10.1056/NEJM198809153191105. [DOI] [PubMed] [Google Scholar]
- Halmi K. A. Anorexia nervosa and bulimia. Annu Rev Med. 1987;38:373–380. doi: 10.1146/annurev.me.38.020187.002105. [DOI] [PubMed] [Google Scholar]
- Halmi K. A. Anorexia nervosa: demographic and clinical features in 94 cases. Psychosom Med. 1974 Jan-Feb;36(1):18–26. doi: 10.1097/00006842-197401000-00002. [DOI] [PubMed] [Google Scholar]
- Halmi K. A., Casper R. C., Eckert E. D., Goldberg S. C., Davis J. M. Unique features associated with age of onset of anorexia nervosa. Psychiatry Res. 1979 Oct;1(2):209–215. doi: 10.1016/0165-1781(79)90063-5. [DOI] [PubMed] [Google Scholar]
- Halmi K. A., Goldberg S. C., Casper R. C., Eckert E. D., Davis J. M. Pretreatment predictors of outcome in anorexia nervosa. Br J Psychiatry. 1979 Jan;134:71–78. doi: 10.1192/bjp.134.1.71. [DOI] [PubMed] [Google Scholar]
- Halmi K. A., Powers P., Cunningham S. Treatment of anorexia nervosa with behavior modification. Effectiveness of formula feeding and isolation. Arch Gen Psychiatry. 1975 Jan;32(1):93–96. doi: 10.1001/archpsyc.1975.01760190095011. [DOI] [PubMed] [Google Scholar]
- Hatsukami D. K., Mitchell J. E., Eckert E. D. Eating disorders: a variant of mood disorders? Psychiatr Clin North Am. 1984 Jun;7(2):349–365. [PubMed] [Google Scholar]
- Herzog D. B. Antidepressant use in eating disorders. Psychosomatics. 1986 Nov;27(11 Suppl):17–23. doi: 10.1016/s0033-3182(86)72598-x. [DOI] [PubMed] [Google Scholar]
- Hsu L. K. Outcome of anorexia nervosa. A review of the literature (1954 to 1978). Arch Gen Psychiatry. 1980 Sep;37(9):1041–1046. doi: 10.1001/archpsyc.1980.01780220079009. [DOI] [PubMed] [Google Scholar]
- Hsu L. K. The treatment of anorexia nervosa. Am J Psychiatry. 1986 May;143(5):573–581. doi: 10.1176/ajp.143.5.573. [DOI] [PubMed] [Google Scholar]
- Hughes P. L., Wells L. A., Cunningham C. J., Ilstrup D. M. Treating bulimia with desipramine. A double-blind, placebo-controlled study. Arch Gen Psychiatry. 1986 Feb;43(2):182–186. doi: 10.1001/archpsyc.1986.01800020092012. [DOI] [PubMed] [Google Scholar]
- Johnson C., Lewis C., Hagman J. The syndrome of bulimia. Review and synthesis. Psychiatr Clin North Am. 1984 Jun;7(2):247–273. [PubMed] [Google Scholar]
- Kaye W. H., Ballenger J. C., Lydiard R. B., Stuart G. W., Laraia M. T., O'Neil P., Fossey M. D., Stevens V., Lesser S., Hsu G. CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry. 1990 Feb;147(2):225–229. doi: 10.1176/ajp.147.2.225. [DOI] [PubMed] [Google Scholar]
- Kaye W. H., Gwirtsman H. E., George D. T., Ebert M. H., Jimerson D. C., Tomai T. P., Chrousos G. P., Gold P. W. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocrinol Metab. 1987 Feb;64(2):203–208. doi: 10.1210/jcem-64-2-203. [DOI] [PubMed] [Google Scholar]
- McCann U. D., Agras W. S. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry. 1990 Nov;147(11):1509–1513. doi: 10.1176/ajp.147.11.1509. [DOI] [PubMed] [Google Scholar]
- Mitchell J. E., Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol. 1984 Aug;4(4):186–193. [PubMed] [Google Scholar]
- Mitchell J. E., Hoberman H., Pyle R. L. An overview of the treatment of bulimia nervosa. Psychiatr Med. 1989;7(4):317–332. [PubMed] [Google Scholar]
- Mitchell J. E., Seim H. C., Colon E., Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med. 1987 Jul;107(1):71–77. doi: 10.7326/0003-4819-107-1-71. [DOI] [PubMed] [Google Scholar]
- Pope H. G., Jr, Hudson J. I., Jonas J. M., Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry. 1983 May;140(5):554–558. doi: 10.1176/ajp.140.5.554. [DOI] [PubMed] [Google Scholar]
- Sabine E. J., Yonace A., Farrington A. J., Barratt K. H., Wakeling A. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol. 1983;15 (Suppl 2):195S–202S. doi: 10.1111/j.1365-2125.1983.tb05866.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schwartz D. M., Thompson M. G. Do anorectics get well? Current research and future needs. Am J Psychiatry. 1981 Mar;138(3):319–323. doi: 10.1176/ajp.138.3.319. [DOI] [PubMed] [Google Scholar]
- Stein G. S., Hartshorn S., Jones J., Steinberg D. Lithium in a case of severe anorexia nervosa. Br J Psychiatry. 1982 May;140:526–528. doi: 10.1192/bjp.140.5.526. [DOI] [PubMed] [Google Scholar]
- Swift W. J., Ritholz M., Kalin N. H., Kaslow N. A follow-up study of thirty hospitalized bulimics. Psychosom Med. 1987 Jan-Feb;49(1):45–55. doi: 10.1097/00006842-198701000-00004. [DOI] [PubMed] [Google Scholar]
- Touyz S. W., Beumont P. J., Glaun D., Phillips T., Cowie I. A comparison of lenient and strict operant conditioning programmes in refeeding patients with anorexia nervosa. Br J Psychiatry. 1984 May;144:517–520. doi: 10.1192/bjp.144.5.517. [DOI] [PubMed] [Google Scholar]
- Walsh B. T. Fluoxetine treatment of bulimia nervosa. J Psychosom Res. 1991;35 (Suppl 1):33–40. doi: 10.1016/0022-3999(91)90111-z. [DOI] [PubMed] [Google Scholar]
- Walsh B. T., Gladis M., Roose S. P., Stewart J. W., Stetner F., Glassman A. H. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry. 1988 May;45(5):471–475. doi: 10.1001/archpsyc.1988.01800290091011. [DOI] [PubMed] [Google Scholar]
- Walsh B. T., Katz J. L., Levin J., Kream J., Fukushima D. K., Weiner H., Zumoff B. The production rate of cortisol declines during recovery from anorexia nervosa. J Clin Endocrinol Metab. 1981 Jul;53(1):203–205. doi: 10.1210/jcem-53-1-203. [DOI] [PubMed] [Google Scholar]
- Wells L. A., Logan K. M. Pharmacologic treatment of eating disorders. Review of selected literature and recommendations. Psychosomatics. 1987 Sep;28(9):470–479. doi: 10.1016/S0033-3182(87)72478-5. [DOI] [PubMed] [Google Scholar]
- Yager J., Kurtzman F., Landsverk J., Wiesmeier E. Behaviors and attitudes related to eating disorders in homosexual male college students. Am J Psychiatry. 1988 Apr;145(4):495–497. doi: 10.1176/ajp.145.4.495. [DOI] [PubMed] [Google Scholar]
- Yager J. The treatment of eating disorders. J Clin Psychiatry. 1988 Sep;49 (Suppl):18–25. [PubMed] [Google Scholar]
- Yates A. Current perspectives on the eating disorders: I. History, psychological and biological aspects. J Am Acad Child Adolesc Psychiatry. 1989 Nov;28(6):813–828. doi: 10.1097/00004583-198911000-00001. [DOI] [PubMed] [Google Scholar]
- Yates A. Current perspectives on the eating disorders: II. Treatment, outcome, and research directions. J Am Acad Child Adolesc Psychiatry. 1990 Jan;29(1):1–9. doi: 10.1097/00004583-199001000-00001. [DOI] [PubMed] [Google Scholar]